JWCAR029
Sponsors
Peking University, Zhao Weili
Conditions
Non Hodgkin Lymphoma
Phase 1
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
NCT03344367
Start: 2017-11-16End: 2022-03-31Target: 20Updated: 2019-07-12
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
NCT03355859
Start: 2018-01-05End: 2022-03-31Target: 10Updated: 2019-07-12